A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease

Eli-Lilly-Co

The main purpose of the study is to evaluate the efficacy and safety of the study drug known as prasugrel for the reduction of Vaso-Occlusive Crisis events in pediatric participants with sickle cell disease. The study will also investigate reduction in daily pain in children who have sickle cell disease.

 

More information: clinicaltrials.gov, ITHANET Clinical Trials